SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-17-001692
Filing Date
2017-02-16
Accepted
2017-02-16 16:09:31
Documents
3
Period of Report
2017-02-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rare-8k_20161231.htm 8-K 21037
2 EX-99.1 rare-ex991_8.htm EX-99.1 174333
3 GRAPHIC g2017021602245081718268.jpg GRAPHIC 348834
  Complete submission text file 0001564590-17-001692.txt   676819
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36276 | Film No.: 17618010
SIC: 2834 Pharmaceutical Preparations